MEPs Against Cancer Round Table
Key Determinants of Inequalities in Cancer Survival across Europe:
The Latest Results of the Eurocare 5 Study
05 December 2013, 14.00 to 16.15, Room Asp5f385
This event was hosted by Alojz Peterle MEP who sent the following letter concerning the outcome of the MAC meeting to fellow members of the European Parliament:
On 5 December 2013 the MEPs Against Cancer group held a roundtable on “Key determinants of Inequalities in cancer Survival across Europe” where the latest results from EUROCARE, the widest collaborative research project comparing cancer survival by country in Europe, were presented.
EUROCARE 5 results were presented, published also in the Lancet Oncology magazine, which shown that the number of adults surviving at least 5 years after the diagnosis has increased steadily over time in all regions of Europe from 1999 to 2007 and yet cancer survival still varies widely between European countries. Despite the promising increase of childhood cancer survival in Eastern Europe, the rate in this region is still 10% to 20% lower than in Western Europe. Please find the conclusions of the study in the attached document.
High representatives from DG SANCO, DG Research and the Joint Research Centre, EUROCARE leaders, cancer registry directors and researchers from Slovakia, Lithuania, Estonia, Croatia, Bulgaria, major EU cancer stakeholders, including ECCO, SIOP-E, ESSO, ECPC, ECL, EPHA, EONS, OECI, EPAAC, MPE, ENCR among others, and endorsed by ESO, ESTRO and ESMO sought to draw attention to the inequalities across the EU ahead of the European Elections and discuss solutions.
Given our views, we decided to support the following high priorities for the future decisions in cancer health policy:
Thank you for your attention and cooperation, I look forward to a fruitful collaboration on the items above.
Alojz Peterle MEPPresident of the MEPs Against Cancer
Last Updated on Thursday, 19 December 2013 15:47
Page 2 of 17